Keying Zhu
Keying Zhu
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
2Department of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA USA
1,2,
Yun Liu
Yun Liu
3State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Sciences, Institutes of Brain Science, Fudan University, Shanghai, China
4MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Disease, Wuxi School of Medicine, Jiangnan University, Wuxi, China
3,4,
Jin-Hong Min
Jin-Hong Min
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Vijay Joshua
Vijay Joshua
5Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
5,
Jianing Lin
Jianing Lin
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Yue Li
Yue Li
6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
6,
Judith C Kreutzmann
Judith C Kreutzmann
6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
6,
Yuxi Guo
Yuxi Guo
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Wenlong Xia
Wenlong Xia
2Department of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA USA
2,
Elyas Mohammadi
Elyas Mohammadi
7Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
7,
Melanie Pieber
Melanie Pieber
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Valerie Suerth
Valerie Suerth
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Yiming Xia
Yiming Xia
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Zaneta Andrusivova
Zaneta Andrusivova
8Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden
8,
Jean-Philippe Hugnot
Jean-Philippe Hugnot
9Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France
10Jinfeng Laboratory, Chongqing, China
9,10,
Shigeaki Kanatani
Shigeaki Kanatani
6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
6,
Per Uhlén
Per Uhlén
6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
6,
Joakim Lundeberg
Joakim Lundeberg
8Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden
8,
Xiaofei Li
Xiaofei Li
7Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
7,
Stephen P J Fancy
Stephen P J Fancy
2Department of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA USA
2,
Heela Sarlus
Heela Sarlus
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,
Robert A Harris
Robert A Harris
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
1,✉,#,
Harald Lund
Harald Lund
11Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
11,✉,#
1Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
2Department of Neurology, Division of Neuroimmunology and Glial Biology, University of California San Francisco, San Francisco, CA USA
3State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Sciences, Institutes of Brain Science, Fudan University, Shanghai, China
4MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Disease, Wuxi School of Medicine, Jiangnan University, Wuxi, China
5Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
6Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
7Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
8Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden
9Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France
10Jinfeng Laboratory, Chongqing, China
11Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Subject terms: Microglia, Oligodendrocyte, Multiple sclerosis
© The Author(s) 2026
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
PDF (557.5 KB)
